ANAPLASTIC THYROID CANCER
Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CANCER trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug cocktail aims to add months for deadly thyroid cancer patients
Disease control Not yet recruitingThis early-phase trial tests whether combining two drugs, zanzalintinib and cemiplimab, can extend survival by about 4 months in people with a rare, fast-growing thyroid cancer called anaplastic thyroid cancer. The study will enroll 12 adults whose cancer has a specific genetic p…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:49 UTC
-
New hope for advanced thyroid cancer: tailored drug cocktails enter trial
Disease control Not yet recruitingThis early-phase trial tests whether it is safe and possible to give people with advanced thyroid cancer a personalized mix of existing drugs chosen based on their tumor's genetic makeup. The study includes 10 patients who have run out of standard treatment options. The goal is t…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE1 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC